Skip to main content

CITIGROUP INC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 831001 NEW YORK, NY

Position in APLS

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
657,223
+5.6% QoQ
Ownership
0.513%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$0
PutShares
60,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-03-31 657,223
2026-03-31 60,000
2025-12-31 622,158
2025-09-30 444,972
2025-06-30 138,451
2025-03-31 416,619
2024-12-31 192,161
2024-12-31 29,000
2024-12-31 29,000
2024-09-30 12,162
2024-06-30 42,669
2024-03-31 261,708
2024-03-31 89,700
2024-03-31 89,700
2023-12-31 86,541
2023-09-30 30,000
2023-09-30 30,000
2023-09-30 116,896
2023-06-30 79,985
2023-06-30 1,600
2023-06-30 20,000
2023-03-31 24,900
2023-03-31 24,900
2023-03-31 123,407
2022-12-31 24,700
2022-12-31 24,700
2022-12-31 82,100
2022-09-30 35,000
2022-09-30 35,000
2022-09-30 97,832
2022-06-30 5,600
2022-06-30 101,960
2022-03-31 12,200
2022-03-31 26,684
2021-12-31 119,688
2021-09-30 70,292
2021-06-30 92,728
2021-03-31 98,074
2020-12-31 95,186
2020-09-30 9,207
2020-06-30 67,785
2020-03-31 52,449